0913693 B.C REPCF Stock
0913693 B.C Price Chart
0913693 B.C REPCF Financial and Trading Overview
| 0913693 B.C stock price | 0.0020 USD |
| Previous Close | 0.18 USD |
| Open | 0.18 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.18 - 0.18 USD |
| 52 Week Range | 0.05 - 0.19 USD |
| Volume | 136.85K USD |
| Avg. Volume | 6.06K USD |
| Market Cap | 11.72M USD |
| Beta (5Y Monthly) | 1.06514 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
REPCF Valuation Measures
| Enterprise Value | 11.63M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 33.119217 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 32.879 |
| Enterprise Value/EBITDA | -7.725 |
Trading Information
0913693 B.C Stock Price History
| Beta (5Y Monthly) | 1.06514 |
| 52-Week Change | 93.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.19 USD |
| 52 Week Low | 0.05 USD |
| 50-Day Moving Average | 0.12 USD |
| 200-Day Moving Average | 0.09 USD |
REPCF Share Statistics
| Avg. Volume (3 month) | 6.06K USD |
| Avg. Daily Volume (10-Days) | 18.21K USD |
| Shares Outstanding | 65M |
| Float | 23.06M |
| Short Ratio | N/A |
| % Held by Insiders | 55.22% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -259.87% |
| Operating Margin (ttm) | -425.81% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -121.0040% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 353.74K USD |
| Revenue Per Share (ttm) | 0.008 USD |
| Quarterly Revenue Growth (yoy) | 0% |
| Gross Profit (ttm) | N/A |
| EBITDA | -1505525 USD |
| Net Income Avi to Common (ttm) | -919267 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 697.26K USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 757.38K USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.566 |
| Book Value Per Share (mrq) | -0.09 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2194473 USD |
| Levered Free Cash Flow (ttm) | -1213566 USD |
Profile of 0913693 B.C
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 570 Granville Street |
| ZIP | V6C 3P1 |
| Phone | 604-248-8730 |
| Website | https://www.replicel.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin; and RCH-01 for the treatment of hair loss. It is also developing RCI-02, a dermal injection device. The company has a collaboration and technology transfer agreement with YOFOTO (China) Health Industry Co. Ltd. for establishing a clinical research program to develop and commercialize RCS-01 and RCT-01; and collaboration and technology transfer agreement with Shiseido Company, Limited for establishing a clinical research program for RCH-01. It also has a collaboration research project agreement with the University of British Columbia to build a hair follicle cell data map. The company is headquartered in Vancouver, Canada.
Q&A For 0913693 B.C Stock
What is a current REPCF stock price?
0913693 B.C REPCF stock price today per share is 0.0020 USD.
How to purchase 0913693 B.C stock?
You can buy REPCF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for 0913693 B.C?
The stock symbol or ticker of 0913693 B.C is REPCF.
Which industry does the 0913693 B.C company belong to?
The 0913693 B.C industry is Biotechnology.
How many shares does 0913693 B.C have in circulation?
The max supply of 0913693 B.C shares is 73.58M.
What is 0913693 B.C Price to Earnings Ratio (PE Ratio)?
0913693 B.C PE Ratio is now.
What was 0913693 B.C earnings per share over the trailing 12 months (TTM)?
0913693 B.C EPS is -0.01 USD over the trailing 12 months.
Which sector does the 0913693 B.C company belong to?
The 0913693 B.C sector is Healthcare.